Literature DB >> 12895500

3-Amino thioacridone, a selective cyclin-dependent kinase 4 inhibitor, attenuates kainic acid-induced apoptosis in neurons.

E Verdaguer1, E G Jordà, A M Canudas, A Jiménez, F X Sureda, V Rimbau, D Pubill, E Escubedo, J Camarasa, M Pallàs, A Camins.   

Abstract

The mechanisms underlying selective neuronal cell death in kainic acid-mediated neurodegeneration are not fully understood. We have recently demonstrated that in cerebellar granule neurons, kainic acid induces the expression of proteins associated with cell-cycle progression. In the present study we show that 3-amino thioacridone (3-ATA), a selective cyclin-dependent kinase 4 inhibitor, attenuates kainic acid-induced apoptosis in cerebellar granule neurons. When neurons were pre-treated with 3-ATA 10 microM for 24 h, they were less susceptible to damage induced by kainic acid 500 microM, since the number of dead cells decreased significantly. In flow cytometry studies using propidium iodide staining, 3-ATA also reduced the ratio of apoptotic cells induced by kainic acid. Moreover, 3-ATA decreased the proportion of cells with a condensed nucleus from 55% to 22%. Our data suggest that the cell cycle pathway is involved in the mechanism of apoptosis mediated by kainic acid and that cyclin-dependent kinase 4 plays a prominent role in this process. 3-ATA may to prevent the apoptosis associated with neurodegenerative disorders without the over-activation of excitatory amino acid receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895500     DOI: 10.1016/s0306-4522(03)00424-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

Review 2.  Cell cycle activation and spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 3.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

Review 4.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

5.  Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.

Authors:  Da-Zhi Liu; Yingfang Tian; Bradley P Ander; Huichun Xu; Boryana S Stamova; Xinhua Zhan; Renee J Turner; Glen Jickling; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-02       Impact factor: 6.200

Review 6.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01

7.  Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5).

Authors:  M V Ramana Reddy; Balireddy Akula; Stephen C Cosenza; Saikrishna Athuluridivakar; Muralidhar R Mallireddigari; Venkat R Pallela; Vinay K Billa; D R C Venkata Subbaiah; E Vijaya Bharathi; Rodrigo Vasquez-Del Carpio; Amol Padgaonkar; Stacey J Baker; E Premkumar Reddy
Journal:  J Med Chem       Date:  2014-01-24       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.